Pharmacy Guild of Australia & VIVA! Communications clinch Australia’s Best Public Health Initiative 2018 at PRIME Awards
Last night (September 20) Team VIVA! celebrated a huge win. Together with the Pharmacy Guild of Australia, we clinched Australia’s‘Best Public Health Initiative 2018’award for our ‘Enhancing ‘community immunity’ through pharmacist-led flu vaccinationcampaign at the pharmaceutical industry’s annual PRIME Awards. Held at The Four Seasons Hotel, Sydney, the event attracted more than 800 of the…
ACCC announces clearance of the merger of Arrow Pharmaceuticals & Apotex Australia & NZ merger
Melbourne, September 20, 2018 – The Australian Competition and Consumer Commission (ACCC) announced this morning that it ‘has decided not to oppose the merger of generic pharmaceutical companies, Arrow and Apotex’ after finding the transaction would not substantially lessen competition in any market. In May 2018, Strides Pharma Science Ltd and Apotex Inc. announced their…
GLOBALHealthPR appoints VIVA! Communications ‘Asia-Pacific hub’ & welcomes Spurwing Communications as exclusive Singaporean partner
GLOBALHealthPR, the world’s largest partnership of independent health and science communications agencies, today appointed longstanding Australian partner, VIVA! Communications, ‘regional hub’ for Asia-Pacific. The strategic partnership also welcomed Singapore-based Spurwing Communications to its network today, further strengthening GLOBALHealthPR’s capabilities in the Asia-Pacific (APAC) region. Having earned an enviable reputation for servicing the local, regional and…
The osteoporosis care gap
The release of the Australia and New Zealand Hip Fracture Registry (ANZHFR) 2018 annual reporthas revealed a significant need for improvement in the management and prevention of osteoporotic fractures in our elderly population. There is a call for hospitals to prioritise osteoporosis treatment plans when discharging patients following a hip fracture. This follows data revealing…
New report card on Aussie blokes health + wellness
Findings from a bodyandsoul-commissioned YouGov Galaxy survey released Sunday, September 2, 2018 provide some quirky insights into the current state of Aussie men’s health and wellness. According to the online survey, which captured responses from more than 1,000 men Australia-wide: 68 per cent of respondents had undergone a blood pressure check and 59 per cent…
Fundraising success for the RSPCA as Dogust draws to a close
As GLOBALHealthPR (GHPR) initiative #Dogust draws to conclusion, VIVA! Communications is celebrating the roaring success of our recent fundraising bake sale for the RSPCA. Generating more than $170 through in-person donations alone, VIVA! raised the dough this year by 34 per cent in comparison to the same event last year. Celebrating ‘Cupcake Day’, an annual…
Every drop counts – World Water Week 2018
This week is the World Water Week (WWW) Forum 2018 and this year’s focus is on ‘Water, ecosystems and human development’. Every year, WWW provides a platform for over 300 organisations to consider the latest research and encourage new thinking and positive action towards water-related issues worldwide. Around 1.1 billion people around the world do not…
Doctors sound alarm bell at lack of qualified nurses in aged care sector
Doctors have this week raised an alarm regarding the lack of qualified nurses working in the Australian aged care sector. According to the AMA’s most recent Aged Care survey, 35% of doctor respondents plan to stop accepting new patients, to reduce or completely cease their aged-care visits within the next two years. The survey involved…
Pharmaxis granted FDA clearance to produce Aridol locally for US market
ASX-listed pharmaceutical company, Pharmaxis has today been granted FDA clearance to commence Sydney-based production of its asthma diagnostic medication, Aridol for the US. The approval follows hot-on-the-heels of the FDA’s recent inspection of the Sydney facility which manufactures Aridol for Australia, South Korea and Europe, and Bronchitol for Australia, Europe and Russia respectively. Following FDA…
Doctors encouraging middle-aged Aussie blokes to consider their prostate
Doctors are encouraging middle-aged Aussie blokes to have their prostate checked.Their call coincides with an article published in MJA Insight today (Monday, August 13), citing benign prostatic hyperplasia (BPH) – or a benign enlargement of the prostate – can compromise a man’s quality of life, and his relationships with his partner and family.2 According…